sglt2 inhibitors and glp 1 receptor agonists Use of GLP-1 Among Patients with Type Diabetes: A Nationwide Register-Based Cohort Study Perioperative GLP-1/GIP & SGLT2 Inhibitors

If you have questions, please contact your Fisher Phillips attorney, the authors of this Insight, any attorney in our Employee Benefits and Tax Practice Group

Combination therapies, novel receptor targets, and alternative delivery systems are in development, aiming to improve efficacy, tolerability, and convenience

Obesity and impaired metabolic health increase risk of COVID-19-Related mortality in young and middle-aged adults to the level observed in older people: The LEOSS registry

[DOI] [PMC free article] [PubMed] [Google Scholar] 57.Richards JR, Dorand MF, Royal K, Mnajjed L, Paszkowiak M, Simmons WK

J Diabetes Metab Disord